Cost-effectiveness of mass screening for dipstick hematuria in Japan

[1]  Yair Lotan,et al.  Should we screen for bladder cancer in a high‐risk population? , 2006, Cancer.

[2]  T. Ninomiya,et al.  The effect of renin–angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy , 2016, Clinical and Experimental Nephrology.

[3]  Hideto Takahashi,et al.  Prognosis of Asymptomatic Hematuria and/or Proteinuria in Men , 2002, Nephron.

[4]  Nihon Jinzō Gakkai.  [Japanese guidelines of the management of hematuria]. , 2013, Nihon Jinzo Gakkai shi.

[5]  W. van Biesen,et al.  Renal Biopsy in 2015 - From Epidemiology to Evidence-Based Indications , 2016, American Journal of Nephrology.

[6]  K. Iseki.  Evidence for asymptomatic microhematuria as a risk factor for the development of ESRD. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  Koshiro Fukiyama,et al.  Outcome study of renal biopsy patients in Okinawa, Japan. , 2004, Kidney international.

[8]  T. Wollin,et al.  Canadian guidelines for the management of asymptomatic microscopic hematuria in adults. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[9]  B. C. Kwan,et al.  Asymptomatic isolated microscopic haematuria: long-term follow-up. , 2004, QJM : monthly journal of the Association of Physicians.

[10]  E. Messing.  Re: Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis. , 2007, European urology.

[11]  N. Powe,et al.  Screening for proteinuria in US adults: a cost-effectiveness analysis. , 2003, JAMA.

[12]  F. Wang,et al.  Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney disease , 2017, BMC Nephrology.

[13]  R. Stutzman.  Urine Sediment Examination , 1981 .

[14]  Y. Mori,et al.  Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR) , 2012, Clinical and Experimental Nephrology.

[15]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[16]  K. Iseki,et al.  Association of dipstick hematuria with all-cause mortality in the general population: results from the specific health check and guidance program in Japan , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  Hideto Takahashi,et al.  Measurement of health-related quality of life in patients with chronic kidney disease in Japan with EuroQol (EQ-5D) , 2010, Clinical and Experimental Nephrology.

[18]  R. Hattori,et al.  [Clinical importance of microhematuria as an initial sign of bladder tumor]. , 1990, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[19]  A. Sutton,et al.  An early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancer , 2018, PloS one.

[20]  K. Yamagata,et al.  A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. , 1996, Clinical nephrology.

[21]  K. Kitamura,et al.  Long-Term Survival of Patients with IgA Nephropathy After Dialysis Therapy , 2013, Kidney and Blood Pressure Research.

[22]  K. Tsuchiya,et al.  Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria , 2015, Clinical and Experimental Nephrology.

[23]  T. Igarashi,et al.  Strategies for asymptomatic microscopic hematuria: a prospective study of 1,034 patients. , 1990, The Journal of urology.

[24]  S. Boorjian,et al.  Guideline of guidelines: asymptomatic microscopic haematuria , 2018, BJU international.

[25]  H. D. de Koning,et al.  Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer , 2018, BJU international.

[26]  K. Iseki,et al.  Higher cardiovascular mortality in men with persistent dipstick hematuria , 2020, Clinical and Experimental Nephrology.

[27]  Y. Mizutani,et al.  Clinical outcome of tumor recurrence for Ta, T1 non‐muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999–2001 report from the Japanese Urological Association , 2009, International journal of urology : official journal of the Japanese Urological Association.

[28]  S. Bae,et al.  International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? , 2010, Health economics.

[29]  K. Nitta,et al.  Cost‐Effectiveness of Maintenance Hemodialysis in Japan , 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[30]  W. See.  Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis , 2007 .

[31]  J. Whiteside,et al.  Asymptomatic microscopic hematuria in women. , 2017, Current opinion in obstetrics & gynecology.

[32]  K. Sugimura,et al.  Microscopic hematuria as a screening marker for urinary tract malignancies , 2001, International journal of urology : official journal of the Japanese Urological Association.

[33]  H. Mikami,et al.  Japanese guidelines of the management of hematuria 2013 , 2014, Clinical and Experimental Nephrology.

[34]  G. Sanders,et al.  Cost-Effectiveness in Health and Medicine , 2016 .

[35]  K. Iseki,et al.  Risk of developing end-stage renal disease in a cohort of mass screening. , 1996, Kidney international.

[36]  Scott D. Miller,et al.  Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. , 2012, The Journal of urology.

[37]  Yusuke Suzuki,et al.  A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity , 2018, Clinical and Experimental Nephrology.

[38]  N. Siddiqui,et al.  Microhematuria in Postmenopausal Women: Adherence to Guidelines in a Tertiary Care Setting. , 2016, The Journal of urology.

[39]  K. Ohe,et al.  The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. , 2008, International heart journal.

[40]  E. Messing,et al.  Long‐term outcome of hematuria home screening for bladder cancer in men , 2006, Cancer.

[41]  K. Skorecki,et al.  Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. , 2011, JAMA.